Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine in antihistamine-resistant chronic urticaria
2007-007657-31Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic idiopathic urticaria (CIU) comparing Miltefosine (Impavido) with Placebo (2 arms). Started Feb 2008; status: completed.
02
Drugs
miltefosine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on 2007-007657-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007657-31.